This bill establishes three dedicated state funds to mitigate the impact of potential federal cuts to health insurance and Medicaid for Maine residents. It creates a Rural Hospital Stabilization Program that provides grants to rural health care providers to cover operating costs and prevent service closures, with an initial appropriation of $50 million. Additionally, it sets up a Health Care Premium Stabilization Fund to offer state subsidies for insurance premiums if federal Affordable Care Act benefits are reduced or repealed, funded by $17.3 million. The legislation also creates a MaineCare Federal Response Fund, allocated $105 million, to supplement state Medicaid funding and support administrative changes required by new federal eligibility rules. Finally, the bill appropriates $80 million to increase reinsurance for the 2027 coverage year to help stabilize health insurance costs.
This bill provides emergency funding to federally qualified health centers in Maine to help them expand retail pharmacy services in underserved areas. The legislation allocates $699,150 in fiscal year 2026, with $44,250 given to each health center plus an additional $8,850 for each additional site they operate. The funding is intended to support infrastructure that allows these centers to offer prescription drugs more directly to patients when retail pharmacy options are limited. It addresses concerns about reduced pharmacy access in rural areas and conflicting requirements from drug manufacturers under the federal 340B program. The bill takes effect immediately as an emergency measure to preserve public health and safety.
This bill ensures continued funding for Maine's children's residential care facilities by making newly appropriated funds nonlapsing - meaning unspent money carries over to future fiscal years instead of expiring. It directly affects facilities that provide residential care for children and receive reimbursement through MaineCare (the state's Medicaid program), which face potential bed reductions or closures due to funding gaps. The bill removes a requirement for an emergency rate adjustment process for these facilities, streamlining how they receive funding. Key provisions focus on stabilizing financial support to maintain access to critical care services for vulnerable children.
This bill changes prior authorization rules for health insurance plans to improve access to ongoing treatments. It requires that prior authorizations for chronic conditions or long-term care remain valid for the full treatment duration or one year (whichever is longer), and prohibits renewal more frequently than once every five years for treatments lasting over a year. It also prevents health plans from restricting coverage for previously approved medications within 90 days of switching plans, unless the patient's condition changes, and mandates 90 days' notice before any coverage restriction. The bill directly affects patients with chronic conditions and health insurance carriers in Maine.
LD 1123 provides ongoing state funding to establish two Public Service Coordinator positions within the Maine Department of Education. These coordinators will directly assist public school districts in navigating MaineCare (Maine's Medicaid program) reimbursement processes for student health services. The bill allocates $204,172 for the 2025-26 fiscal year and $283,836 for 2026-27 to cover salaries and operational costs for these roles. The key mechanism is creating dedicated staff to provide technical assistance, streamline billing, and improve schools' ability to receive reimbursements for covered health services. This affects all public school districts in Maine that seek MaineCare reimbursement for student health-related services.
This bill requires medical cannabis dispensaries and caregivers to test all cannabis products before selling them to patients, ensuring they meet safety standards for contaminants like pesticides, microbes, and THC potency (max 10mg per serving, with a 10% variance allowance). It mandates testing for harmful substances including pesticides, molds, and PFAS, and requires detailed record-keeping of test results. The bill also directs a portion of adult-use cannabis tax revenue to fund medical cannabis programs and creates a study group to review the program’s effectiveness. These changes directly affect medical cannabis patients, dispensaries, and caregivers in Maine by aligning safety protocols with adult-use standards.
LD 1948 provides a one-time $117,618,761 allocation from the General Fund to MaineCare (Maine's Medicaid program) for fiscal year 2024-25. It directly affects MaineCare recipients and healthcare providers who receive payments through the program. The bill's key mechanism is moving this funding from the General Fund for immediate use in the current fiscal year. Part B of the bill cancels a previously allocated amount from Public Law 2025, chapter 2, Part D, with that cancellation effective June 20, 2025. This is a procedural funding adjustment, not a new policy.
This bill exempts certain over-the-counter (OTC) medicines from Maine's sales tax starting January 1, 2026. It applies to FDA-approved OTC medicines meeting specific labeling requirements, including antacids, contraceptive products, allergy medications, eye/ear/nose treatments, and opioid antagonists. The exemption covers medicines sold directly to consumers without a prescription, but excludes cannabis products. This change affects Maine residents purchasing these specific OTC health products, reducing their out-of-pocket costs for essential medications.
This bill requires Maine's Department of Health and Human Services to apply for federal approval by December 31, 2025, to establish continuous health insurance coverage for children under 6 years old enrolled in Medicaid or the Children's Health Insurance Program (CHIP). Once approved, these children would maintain coverage until their 6th birthday, regardless of changes in their family's income. Coverage could end only if the child moves out of state, a parent requests termination, the child dies, or eligibility was mistakenly granted due to fraud or error.
This bill requires the Maine Department of Health and Human Services to provide free water testing for arsenic and PFAS (perfluoroalkyl substances) to low-income rural households using private wells. It expands existing testing programs by adding PFAS testing through state-approved labs, funded by the department's dedicated testing account, with no fees charged to eligible residents. The bill also mandates educational outreach to inform low-income well owners about the free testing and eligibility for state grants to install water treatment systems if contaminants exceed state standards. These provisions directly affect rural low-income residents relying on private wells, aiming to improve access to safe drinking water through expanded testing and treatment support.
